Catalysts
Catalysts — What Can Move the Stock
Figures converted from JPY at historical FX rates — see data/company.json.fx_rates. Forward-looking figures and recent prices use a rate close to ¥150/USD (the company's FY26 plan assumption); period-specific historical figures use period-end rates. Ratios, margins, and multiples are unitless and unchanged.
The next six months hinge almost entirely on one event: the Q1 FY2026 print on May 15, 2026 — the first quarter that consolidates SENQCIA, the first quarter the FY26 guide is tested under a stronger-yen assumption, and the first quarter U.S. reciprocal tariffs flow through JLab gross margin. Everything else in the window — the residual $9.8M of the $20M buyback, the JMDC sell-down, technical level defense at the 200-day moving average — is second-order until that print resets expectations. The calendar is thin in events but dense in signals: only two hard-dated company prints land before October 29, 2026, but each is a multi-variable test of a thesis the market has not yet underwritten.
Hard-dated catalysts (next 6m)
High-impact catalysts
Days to next hard date
Signal quality (1–5)
The single most important catalyst: Q1 FY2026 results on 2026-05-15. Three independent variables resolve at once — (i) SENQCIA's first consolidation print ($519M acquisition closed 2026-02-13), (ii) JLab gross-margin response to U.S. tariffs after the China-to-Vietnam shift, and (iii) AlphaTheta unit volumes against management's guided revenue decline in 1H from a tough year-ago backlog comp. A clean print resolves all three to the upside; a single miss on any reframes the FY30 plan.
Ranked Catalyst Timeline
The list below is ranked by decision value to a hedge-fund PM, not by chronology. Confidence reflects date verifiability and evidence quality. "Expectation not visible" means consensus is not surfaced in the two-analyst sell-side coverage and must be backsolved from management guidance.
Calendar density is low; signal density is high. Two scheduled corporate events in the next six months (May 15 and ~August 13) carry the entire decision-relevant calendar. The market is not waiting for an unknown event — it is waiting for the next two prints to confirm or invalidate a thesis it already half-believes.
Impact Matrix — Which Catalysts Actually Resolve the Debate
The catalysts that add information are not the same as the catalysts that close the variant. The matrix below isolates the latter — the events that force the bull or bear case to mark to market.
Next 90 Days
The 90-day window is dominated by one print and a finite list of supporting signals. Each item below names what would matter more than the headline.
2026-05-15 — Q1 FY2026 results. Headline numbers will look like a beat against a soft FY26 guide ($1,121M revenue is +41% YoY because SENQCIA is now in). What matters: the AlphaTheta ex-FX growth rate (guide is +8–10% full year, with H1 a negative comp from FY25's backlog clearing) and the JLab gross-margin slope with U.S. tariffs landing. A PM should size the position based on whether segment commentary signals the JLab tariff offset is happening at the price-elasticity assumed.
Through 2026-06-30 — Buyback residual $9.8M execution. $10.3M / 716,700 shares already done by 2026-03-31. The signal is not the completion — it is whether a follow-on tranche is announced before the AGM resolutions stale. A second authorisation in May/June would be a stronger capital-return signal than the original $20M.
Through 2026-06-30 — JMDC sell-down completion. Management announced sale of 1,307,100 JMDC shares from Feb 17 to Jun 30. A PM should track the disclosed proceeds — at JMDC's recent market price the cash-in is ~$67–100M, which is roughly the size of the residual buyback authorisation. The redeployment matters: cash → buyback closes the loop; cash → SENQCIA debt or M&A reserve does not.
Continuous — Tape vs $12.48 (200-day SMA) and $14.72 reclaim. A pre-Q1 break below $12.48 on volume signals the market has already concluded the print will disappoint; a reclaim of $14.72 ahead of May 15 signals positioning expects an upside surprise. The 50/200 golden cross from 2025-08-04 is still intact — the death cross that printed 2026-03-27 was the faster 20/50 only.
Speculative window — A "fourth business" follow-up announcement or Teibow MIM/nibs separation flag. Neither is on a calendar. But an announcement of either would be the second-order capital-allocation signal the market is waiting for — and the market is short the fact that they have not happened.
What Would Change the View
Three observable signals, ranked, would most change the investment debate over the next six months. First, the Q1 FY2026 segment table — specifically the JLab gross-margin sequence and the SENQCIA stand-alone EBITDA disclosure — is the single piece of evidence that resolves the "FX-flattered margin + soft-asset risk + conglomerate cash trap" bear thesis (or confirms it). Second, a follow-on buyback authorisation announced before the August print would force the bear to reweight the controlling-shareholder-extraction risk lower; conversely, no follow-on plus an undisclosed redeployment of JMDC proceeds would force the bull to mark down the float-shrink rerate path. Third, any management commentary that walks back the $1,271M FY30 revenue plan — even softly, even without a formal cut — would force the variant case (cheap on numbers, but underwriting a plan that no longer compounds at the planned rate) to dominate the debate. None of these are "events" in the press-release sense; all three are statements that will exist or not exist after May 15, 2026, and August 13, 2026.